NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2
Canadian Journal of Gastroenterology and Hepatology · 2021-01 · 2021 (1)
DOI: 10.1155/2021/6613827 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Canadian Journal of Gastroenterology and Hepatology, online erschienen am 17.02.2021. Verfasst von Marinko Marušić und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haepatogastroenterology, University Hospital Sveti Duh, Zagreb, Croatia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Insulin Resistance, Metabolic Syndrome, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 161-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Nonalcoholic fatty liver disease is a condition defined by fat accumulation in hepatocytes not promoted by excessive alcohol consumption. It is highly prevalent and is strongly associated with insulin resistance, metabolic syndrome, and diabetes type II. Insulin resistance plays a crucial role in the multifactorial etiopathogenesis of this condition leading to accumulation of free fatty acids in the liver cells, thus causing lipotoxicity, inflammation, and fibrosis. In this review, we will focus on currently known pathogenesis of nonalcoholic fatty liver disease. Numerous investigation strategies are available to establish the diagnosis, from biochemical markers and ultrasound to various molecular and advanced imaging techniques and liver biopsy. Prevention is crucial. However, effective and promising therapies are strongly demanded.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Haepatogastroenterology, University Hospital Sveti Duh, Zagreb, Croatia.
- Faculty of Medicine, J.J. Strossmayer University of Osijek, Osijek, Croatia.
- Faculty of Health Studies, University of Rijeka, Rijeka, Croatia.
- Department of Endocrinology and Diabetology, University Hospital Sveti Duh, Zagreb, Croatia.
ORCID-Profile: Marinko Marušić, Matej Paić, Mia Knobloch, Ana-Marija Liberati Pršo
Zitieren
APA
Marušić, M., Paić, M., Knobloch, M., & Liberati Pršo, A. M. (2021). NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2. Canadian Journal of Gastroenterology and Hepatology, 2021(1). https://doi.org/10.1155/2021/6613827
Vancouver
Marušić M, Paić M, Knobloch M, Liberati Pršo AM. NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2. Canadian Journal of Gastroenterology and Hepatology. 2021;2021(1). doi:10.1155/2021/6613827
BibTeX
@article{Marui2021,
author = {Marušić, Marinko and Paić, Matej and Knobloch, Mia and Liberati Pršo, Ana-Marija},
title = {NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2},
journal = {Canadian Journal of Gastroenterology and Hepatology},
year = {2021},
volume = {2021},
number = {1},
doi = {10.1155/2021/6613827}
}
EUVIMED